Search

D. Margaret M. Seaman

Examiner (ID: 14125, Phone: (571)272-0694 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1625, 1612, 1621, 1203
Total Applications
3093
Issued Applications
2274
Pending Applications
282
Abandoned Applications
572

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13687247 [patent_doc_number] => 20170354578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => Preparation of Zinc Citrate and of Zinc Citrate-Containing Oral Care Compositions [patent_app_type] => utility [patent_app_number] => 15/521058 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521058 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/521058
Preparation of zinc citrate and of zinc citrate-containing oral care compositions Oct 23, 2014 Issued
Array ( [id] => 9793411 [patent_doc_number] => 20150005355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'COMBINATION THERAPY WITH PARP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/485307 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13661 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485307 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/485307
COMBINATION THERAPY WITH PARP INHIBITORS Sep 11, 2014 Abandoned
Array ( [id] => 9793410 [patent_doc_number] => 20150005354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'Combination Therapy With Parp Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/484971 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10456 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484971 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/484971
Combination Therapy With Parp Inhibitors Sep 11, 2014 Abandoned
Array ( [id] => 9895145 [patent_doc_number] => 20150050343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'METHODS OF WOUND CARE AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/336558 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 64557 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336558 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/336558
METHODS OF WOUND CARE AND TREATMENT Jul 20, 2014 Abandoned
Array ( [id] => 9812066 [patent_doc_number] => 20150024010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'METHODS OF THERAPEUTIC TREATMENT OF EYES' [patent_app_type] => utility [patent_app_number] => 14/336307 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 65557 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336307 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/336307
METHODS OF THERAPEUTIC TREATMENT OF EYES Jul 20, 2014 Abandoned
Array ( [id] => 9909049 [patent_doc_number] => 20150064251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'Tamper Resistant Dosage Form Composition And Process Of Making The Same' [patent_app_type] => utility [patent_app_number] => 14/323412 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8498 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323412 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/323412
Tamper Resistant Dosage Form Composition And Process Of Making The Same Jul 2, 2014 Abandoned
Array ( [id] => 10255114 [patent_doc_number] => 20150140111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/309273 [patent_app_country] => US [patent_app_date] => 2014-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11791 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309273 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/309273
PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF Jun 18, 2014 Abandoned
Array ( [id] => 9719798 [patent_doc_number] => 20140255497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 14/285808 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6815 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285808 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/285808
Organic Compounds May 22, 2014 Abandoned
Array ( [id] => 10620565 [patent_doc_number] => 09339489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Rapid disperse dosage form containing levetiracetam' [patent_app_type] => utility [patent_app_number] => 14/277901 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 7 [patent_no_of_words] => 17484 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14277901 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/277901
Rapid disperse dosage form containing levetiracetam May 14, 2014 Issued
Array ( [id] => 10443150 [patent_doc_number] => 20150328162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'PHARMACEUTICAL PREPARATIONS' [patent_app_type] => utility [patent_app_number] => 14/278772 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2476 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14278772 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/278772
PHARMACEUTICAL PREPARATIONS May 14, 2014 Abandoned
Array ( [id] => 15604211 [patent_doc_number] => 10583146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Pharmaceutical compositions for glucocorticoid replacement therapy [patent_app_type] => utility [patent_app_number] => 14/255332 [patent_app_country] => US [patent_app_date] => 2014-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14516 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255332 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/255332
Pharmaceutical compositions for glucocorticoid replacement therapy Apr 16, 2014 Issued
Array ( [id] => 12465981 [patent_doc_number] => 09987233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-05 [patent_title] => Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith [patent_app_type] => utility [patent_app_number] => 14/222082 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 14006 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14222082 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/222082
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith Mar 20, 2014 Issued
Array ( [id] => 10919277 [patent_doc_number] => 20140322296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'PIPERAQUINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM' [patent_app_type] => utility [patent_app_number] => 14/222102 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9780 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14222102 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/222102
PIPERAQUINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM Mar 20, 2014 Abandoned
Array ( [id] => 15449287 [patent_doc_number] => 10548874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-04 [patent_title] => Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof [patent_app_type] => utility [patent_app_number] => 14/200292 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18168 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14200292 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/200292
Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof Mar 6, 2014 Issued
Array ( [id] => 9568736 [patent_doc_number] => 20140186449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'CONTROLLED RELEASE PREPARATION' [patent_app_type] => utility [patent_app_number] => 14/199334 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71917 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199334 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/199334
CONTROLLED RELEASE PREPARATION Mar 5, 2014 Abandoned
Array ( [id] => 9805297 [patent_doc_number] => 20150017241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'ORAL FORMULATIONS OF DEFERASIROX' [patent_app_type] => utility [patent_app_number] => 14/198872 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7698 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198872 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/198872
Oral formulations of deferasirox Mar 5, 2014 Issued
Array ( [id] => 9568735 [patent_doc_number] => 20140186448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'CONTROLLED RELEASE PREPARATION' [patent_app_type] => utility [patent_app_number] => 14/199308 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71917 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199308 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/199308
CONTROLLED RELEASE PREPARATION Mar 5, 2014 Abandoned
Array ( [id] => 10654525 [patent_doc_number] => 20160000669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE' [patent_app_type] => utility [patent_app_number] => 14/771062 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19555 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771062 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/771062
Resorcinol compounds for dermatological use Mar 5, 2014 Issued
Array ( [id] => 10662327 [patent_doc_number] => 20160008471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'TRANSDERMAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/771192 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32106 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771192 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/771192
TRANSDERMAL FORMULATIONS Feb 26, 2014 Abandoned
Array ( [id] => 9756299 [patent_doc_number] => 20140287000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'TUMOR PROLIFERATION INHIBITOR CONTAINING ULTRASOUND-SENSITIVE SUBSTANCE AND METHOD FOR INHIBITING TUMOR PROLIFERATION BY USING TUMOR PROLIFERATION INHIBITOR AND LOW-INTENSITY PULSED ULTRASOUND WAVES' [patent_app_type] => utility [patent_app_number] => 14/186859 [patent_app_country] => US [patent_app_date] => 2014-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3146 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186859 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/186859
Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation by using tumor proliferation inhibitor and low-intensity pulsed ultrasound waves Feb 20, 2014 Issued
Menu